CausalSentinel

Protein Dossier — ACP5 (Tartrate-resistant acid phosphatase type 5)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Paget’s disease -0.584 0.175 8.52e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.166 0.0516 0.00132 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids 0.118 0.0433 0.00623 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema -0.101 0.0373 0.00694 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0262 0.00979 0.00744 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypopituitarism 0.554 0.255 0.0299 Wald ratio 1 cis NA
Sodium in urine 0.016 0.00745 0.032 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine 0.015 0.00724 0.038 Wald ratio 1 cis NA
Ischemic stroke -0.103 0.0499 0.0388 Wald ratio 1 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis -0.157 0.0771 0.0421 Wald ratio 1 cis NA
Bulimia nervosa -0.0454 0.0227 0.0455 Wald ratio 1 cis NA
HOMA-B -0.0206 0.0105 0.0499 Wald ratio 1 cis NA
…and 76 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3232_28_2 TrATPase Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

10 association rows across 4 traits (9 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating ACP5 levels 6e-971 rs2305799 4 GCST90859953 no MR -> candidate analysis
ACP5 protein levels 2e-208 rs147025508 2 GCST90468203 no MR -> candidate analysis
Tartrate-resistant acid phosphatase type 5 levels 2e-77 rs7256770 3 GCST90425665 no MR -> candidate analysis
Cerebrospinal fluid protein ACP5 levels 2e-42 rs2071484 1 GCST90944664 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1599 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Spondyloenchondrodysplasia with immune dysregulation 0.909 established (curated) no MR -> candidate analysis
hereditary disease 0.771 established (curated) no MR -> candidate analysis
Alzheimer disease 0.302 common-variant locus no MR -> candidate analysis
thrombophilia 0.336 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.206 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Tartrate-resistant acid phosphatase type 5)
gnomAD constraint pLI=1.1e-07, LOEUF=1.18 — LoF-tolerant
GWAS Catalog 49 unique SNPs / 98 rows
ClinVar 368 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance